Literature DB >> 10461883

Calnexin and the immunoglobulin binding protein (BiP) coimmunoprecipitate with AMPA receptors.

M E Rubio1, R J Wenthold.   

Abstract

To identify proteins that interact with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors, we carried out coimmunoprecipitation analyses on detergent-solubilized rat forebrain membranes. Membranes were solubilized with Triton X-100, and immunoprecipitation was done using subunit-specific antibodies to GluR1, GluR2/3, and GluR4 attached to protein Aagarose. Proteins bound to the antibodies were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by silver staining and western blotting. With solubilization in low ionic strength buffer, several coimmunoprecipitating proteins, with Mr = 17,000-100,000, were identified in silver-stained gels. Western blots were then probed with antibodies to a series of candidate proteins that were chosen based on the molecular masses of the copurifying proteins. Two of these were identified as the molecular chaperones calnexin (90 kDa) and the immunoglobulin binding protein (BiP; 78 kDa). Immunoprecipitation with antibodies to calnexin and BiP demonstrated that glycosylated AMPA receptor subunits were associated. The relationship between AMPA receptors and calnexin and BiP was further studied with immunocytochemistry of the hippocampus. Both calnexin and BiP labeling was present not only in the cell body but also in dendrites of hippocampal pyramidal neurons, where double-label immunofluorescence also showed the presence of AMPA receptor subunits.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461883     DOI: 10.1046/j.1471-4159.1999.0730942.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

Review 1.  Selective targeting of glutamate receptors in neurons.

Authors:  M E Rubio
Journal:  Mol Neurobiol       Date:  2000 Feb-Apr       Impact factor: 5.590

2.  Monaural conductive hearing loss alters the expression of the GluA3 AMPA and glycine receptor α1 subunits in bushy and fusiform cells of the cochlear nucleus.

Authors:  H Wang; G Yin; K Rogers; C Miralles; A L De Blas; M E Rubio
Journal:  Neuroscience       Date:  2011-10-20       Impact factor: 3.590

3.  Ultrastructure, synaptic organization, and molecular components of bushy cell networks in the anteroventral cochlear nucleus of the rhesus monkey.

Authors:  R Gómez-Nieto; M E Rubio
Journal:  Neuroscience       Date:  2011-02-01       Impact factor: 3.590

Review 4.  Assembly of AMPA receptors: mechanisms and regulation.

Authors:  Quan Gan; Catherine L Salussolia; Lonnie P Wollmuth
Journal:  J Physiol       Date:  2014-08-01       Impact factor: 5.182

Review 5.  Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Authors:  G J Lees
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

6.  Synapse-associated protein 97 selectively associates with a subset of AMPA receptors early in their biosynthetic pathway.

Authors:  N Sans; C Racca; R S Petralia; Y X Wang; J McCallum; R J Wenthold
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 7.  From genetics to structure to function: exploring sleep in Drosophila.

Authors:  Daniel Bushey; Chiara Cirelli
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

8.  Stargazin is an AMPA receptor auxiliary subunit.

Authors:  Wim Vandenberghe; Roger A Nicoll; David S Bredt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-03       Impact factor: 11.205

Review 9.  Regulation of AMPA receptor trafficking and exit from the endoplasmic reticulum.

Authors:  Joseph E Pick; Edward B Ziff
Journal:  Mol Cell Neurosci       Date:  2018-03-12       Impact factor: 4.314

10.  Molecular chaperone BiP interacts with Borna disease virus glycoprotein at the cell surface.

Authors:  Tomoyuki Honda; Masayuki Horie; Takuji Daito; Kazuyoshi Ikuta; Keizo Tomonaga
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.